Oculopharyngeal Muscular Dystrophy Stocks List
Related Industries: Drug Manufacturers - Specialty & Generic
Related Stock Lists:
Ai Technology
Biology
Biopharmaceutical
Biotechnology
Chemotherapy
Chronic And Life Threatening Conditions
Clinical Applications
Dystrophy
Gene Expression
Gene Silencing
Genetic Engineering
Genetics
HIV/Aids
Hepatitis B
Hepatitis C
Huntington's Disease
Macular Degeneration
Muscular Dystrophy
Pain
RNA
Date | Stock | Title |
---|---|---|
Mar 24 | BNTC | 11 Best ASX Stocks To Buy Now |
Related Industries:
Drug Manufacturers - Specialty & Generic
Related Stock Lists:
Ai Technology
Biology
Biopharmaceutical
Biotechnology
Chemotherapy
Chronic And Life Threatening Conditions
Clinical Applications
Dystrophy
Gene Expression
Gene Silencing
Genetic Engineering
Genetics
HIV/Aids
Hepatitis B
Hepatitis C
Huntington's Disease
Macular Degeneration
Muscular Dystrophy
Pain
RNA
- Oculopharyngeal Muscular Dystrophy
Oculopharyngeal Muscular Dystrophy (OPMD) is a rare, inherited form of muscular dystrophy that affects the eyes, throat, and upper arms. It is characterized by progressive weakness and wasting of the muscles of the eyes, throat, and upper arms. Symptoms typically begin in adulthood and include drooping eyelids, difficulty swallowing, and weakness in the shoulder and arm muscles. OPMD is caused by a mutation in the PABPN1 gene. Treatment is focused on managing symptoms and may include physical therapy, speech therapy, and medications.
Popular Now
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles